Brief: Sana Biotechnology Q4 adjusted net loss USD 77.193 million
16/03/2023 20:16
Mar 16 (Reuters) - Sana Biotechnology Q4 EPS USD -0.42. * Q4 adjusted net income USD -77.193 million * Q4 net income USD -80.443 million * Q4 operating expenses USD 81.788 million * Q4 adjusted EPS USD -0.4
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17